Emergent Biosolutions Inc
EBS
Market Cap$343.04M
Close$
$0.90
85.1% downside
Current Fair Value
85.1% downsideOvervalued by 85.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $343.04 Million |
|---|---|
| Enterprise Value | $917.74 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.6 |
| Beta | 2.09 |
| Outstanding Shares | 54,400,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.61 |
|---|---|
| PEG | -0.4 |
| Price to Sales | 0.34 |
| Price to Book Ratio | 0.61 |
| Enterprise Value to Revenue | 0.94 |
| Enterprise Value to EBIT | 4.61 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.79 |
| Debt to Equity | 1.31 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Emergent Biosolutions Inc
CEO: Robert Kramer